Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL44 (11-isosparteine, 4',5,7-trihydroxyisoflavone, .alpha.-isospartein, (-)-.alpha.-isosparteine, .alpha.-isosparteine, .alpha.-isosparteine, (-)-, .alpha.-sparteine, BIO 300, BIO-300, Bonistein, FW-635I-2, Genistein, Genisteina, Genisteine, Genisteine-alkaloid, Isosparteine, alpha-, NPI-031L, NSC-36586, NSC-366737, SIPI-807-1, Sophoricol, Sparteine l-.alpha.-isosparteine) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
acetylcholinesterase (Yt blood group)/Acetylcholinesterase in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3199] [GtoPdb: 2465] [UniProtKB: P37136] | ||||||||
ChEMBL | Inhibition of rat cortex AChE using acetylthiocholine as substrate incubated for 15 mins by DTNB reagent based Ellman's method | B | 4.3 | pIC50 | >50000 | nM | IC50 | Bioorg Med Chem Lett (2022) 60: 128574-128574 [PMID:35065231] |
A1 receptor/Adenosine A1 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL226] [GtoPdb: 18] [UniProtKB: P30542] | ||||||||
ChEMBL | DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX) | B | 4.94 | pKi | 11611 | nM | Ki | DrugMatrix in vitro pharmacology data |
ChEMBL | DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX) | B | 4.7 | pIC50 | 19904 | nM | IC50 | DrugMatrix in vitro pharmacology data |
A1 receptor/Adenosine A1 receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL318] [GtoPdb: 18] [UniProtKB: P25099] | ||||||||
ChEMBL | Tested for the displacement [3H]PIA from Adenosine A1 receptor in rat brain membrane | B | 5.3 | pKi | 5000 | nM | Ki | J Med Chem (1996) 39: 398-406 [PMID:8558508] |
ChEMBL | Displacement of specific [3H]PIA binding from adenosine A1 receptor in rat brain membranes. | B | 5.3 | pKi | 5000 | nM | Ki | J Med Chem (1996) 39: 781-788 [PMID:8576921] |
A2A receptor/Adenosine A2a receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL251] [GtoPdb: 19] [UniProtKB: P29274] | ||||||||
ChEMBL | DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA) | B | 5.01 | pKi | 9792 | nM | Ki | DrugMatrix in vitro pharmacology data |
ChEMBL | DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA) | B | 4.76 | pIC50 | 17442 | nM | IC50 | DrugMatrix in vitro pharmacology data |
A2A receptor/Adenosine A2a receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL302] [GtoPdb: 19] [UniProtKB: P30543] | ||||||||
ChEMBL | Displacement [3H]-CGS-21,680 from Adenosine A2A receptor in rat striatal membrane. | B | 4.44 | pKi | 36000 | nM | Ki | J Med Chem (1996) 39: 398-406 [PMID:8558508] |
ChEMBL | Affinity at Adenosine A2A receptor in rat striatal membranes by [3H]- CGS 21680 displacement. | B | 4.44 | pKi | 36000 | nM | Ki | J Med Chem (1996) 39: 781-788 [PMID:8576921] |
Alcohol sulfotransferase in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3007] [UniProtKB: P15709] | ||||||||
ChEMBL | Inhibition of rat SULT2A1-mediated dehydroepiandrosterone sulfonation incubated for 20 mins | B | 4.47 | pIC50 | 34000 | nM | IC50 | Eur J Med Chem (2021) 213: 113037-113037 [PMID:33257172] |
aldehyde oxidase 1/Aldehyde oxidase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3257] [GtoPdb: 3186] [UniProtKB: Q06278] | ||||||||
ChEMBL | Inhibition of human liver AOX using phthalazine as substrate incubated for 2.5 mins by HPLC-MS analysis | B | 8.3 | pIC50 | 5 | nM | IC50 | Eur J Med Chem (2020) 187: 111948-111948 [PMID:31877540] |
aldo-keto reductase family 1 member B/Aldose reductase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1900] [GtoPdb: 2768] [UniProtKB: P15121] | ||||||||
ChEMBL | Inhibition of human recombinant aldose reductase using D-glyceraldehyde as substrate preincubated for 10 mins before substrate addition measured for every 10 secs for 50 mins by spectrophotometry | B | 4.7 | pIC50 | 20000 | nM | IC50 | Bioorg Med Chem (2012) 20: 1251-1258 [PMID:22261024] |
aldo-keto reductase family 1 member B/Aldose reductase in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2622] [GtoPdb: 2768] [UniProtKB: P07943] | ||||||||
ChEMBL | DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde) | B | 4.35 | pIC50 | 44979 | nM | IC50 | DrugMatrix in vitro pharmacology data |
Alpha-glucosidase MAL62 in Saccharomyces cerevisiae (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4357] [UniProtKB: P07265] | ||||||||
ChEMBL | Inhibition of baker's yeast alpha-glucosidase using p-nitrophenyl-alpha-D-glucopyranoside as substrate by spectrophotometry | B | 0.84 | pIC50 | 0.84 | - | logIC50 | Med Chem Res (2012) 21: 3984-3993 |
Alpha-L-fucosidase 1 in Bovine (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3545] [UniProtKB: Q2KIM0] | ||||||||
ChEMBL | Inhibition of bovine kidney alpha-fucosidase using PNPG as substrate incubated for 10 mins by spectrophotometric method | B | 4.27 | pIC50 | 54000 | nM | IC50 | Eur J Med Chem (2020) 188: 112034-112034 [PMID:31927314] |
Alpha-mannosidase in Canavalia ensiformis (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3392945] [UniProtKB: C0HJB3] | ||||||||
ChEMBL | Inhibition of jack bean alpha-mannosidase using PNPG as substrate incubated for 10 mins by spectrophotometric method | B | 4.31 | pIC50 | 49000 | nM | IC50 | Eur J Med Chem (2020) 188: 112034-112034 [PMID:31927314] |
Androgen receptor/Androgen Receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3072] [GtoPdb: 628] [UniProtKB: P15207] | ||||||||
ChEMBL | Inhibitory concentration against recombinant rat androgen receptor expressed in Escherichia coli using [3H]methyltrienolone (R 1881) | B | 4.07 | pIC50 | 85113.8 | nM | IC50 | J Med Chem (2005) 48: 5666-5674 [PMID:16134935] |
Arachidonate 15-lipoxygenase in Rabbit (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4358] [UniProtKB: P12530] | ||||||||
ChEMBL | DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid) | B | 5.04 | pIC50 | 9033 | nM | IC50 | DrugMatrix in vitro pharmacology data |
Aryl sulfotransferase in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4886] [UniProtKB: P17988] | ||||||||
ChEMBL | Inhibition of rat liver SULT1A1-mediated oestradiol sulfonation incubated for 20 mins | B | 6.54 | pIC50 | 290 | nM | IC50 | Eur J Med Chem (2021) 213: 113037-113037 [PMID:33257172] |
ABCG2/ATP-binding cassette sub-family G member 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5393] [GtoPdb: 792] [UniProtKB: Q9UNQ0] | ||||||||
ChEMBL | Inhibition of BCRP expressed in MCF-7 MX cells using Hoechst 33342 staining | B | 5.06 | pIC50 | 8800 | nM | IC50 | Bioorg Med Chem (2011) 19: 2090-2102 [PMID:21354800] |
ChEMBL | Inhibition of BCRP expressed in MDCK cells using Hoechst 33342 staining | B | 5.16 | pIC50 | 6900 | nM | IC50 | Bioorg Med Chem (2011) 19: 2090-2102 [PMID:21354800] |
Butyrylcholinesterase in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3403] [UniProtKB: Q9JKC1] | ||||||||
ChEMBL | Inhibition of rat serum Butyrylcholine esterase using butyrylthiocholine as substrate incubated for 15 mins by DTNB reagent based Ellman's method | B | 4.3 | pIC50 | >50000 | nM | IC50 | Bioorg Med Chem Lett (2022) 60: 128574-128574 [PMID:35065231] |
casein kinase 2, alpha 1 polypeptide subunit/casein kinase 2, beta polypeptide subunit/Casein kinase 2 in Rat (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL3988629] [GtoPdb: 1549, 1551] [UniProtKB: P19139, P67874] | ||||||||
ChEMBL | Inhibition of rat liver CK2 phosphorylation using RRRADDSDDDDD as substrate in presence of [32p]-ATP | B | 4.49 | pIC50 | 32000 | nM | IC50 | J Med Chem (2023) 66: 2257-2281 [PMID:36745746] |
Cruzipain in Trypanosoma cruzi (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3563] [UniProtKB: P25779] | ||||||||
ChEMBL | Inhibition of Trypanosoma cruzi cruzaine using Z-Phe-Arg-aminomethylcoumarin as substrate incubated for 5 mins by spectrofluorimetric analysis in absence of Tween-80 | B | 4.08 | pIC50 | 82700 | nM | IC50 | J Med Chem (2013) 56: 2406-2414 [PMID:23437772] |
COX-1 /Cyclooxygenase-1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL221] [GtoPdb: 1375] [UniProtKB: P23219] | ||||||||
ChEMBL | Inhibition of COX1 | B | 4.1 | pIC50 | 80000 | nM | IC50 | J Nat Prod (2005) 68: 985-991 [PMID:16038536] |
CFTR/Cystic fibrosis transmembrane conductance regulator in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4051] [GtoPdb: 707] [UniProtKB: P13569] | ||||||||
ChEMBL | Potentiation of wild-type CFTR (unknown origin) expressed in FRT cells assessed as chloride transport by measuring membrane potential in presence of forskolin | B | 4.85 | pEC50 | 14200 | nM | EC50 | J Med Chem (2021) 64: 7241-7260 [PMID:34028270] |
ChEMBL | Potentiation of CFTR F508del mutant (unknown origin) expressed in CHO cells assessed as chloride transport by measuring membrane potential incubated for 5 to 30 mins in presence of forskolin by Quattro assay | B | 5.07 | pEC50 | 8480 | nM | EC50 | J Med Chem (2021) 64: 7241-7260 [PMID:34028270] |
ChEMBL | Potentiation of CFTR F508del mutant (unknown origin) expressed in CHO cells assessed as chloride transport by measuring membrane potential preincubated for 5 mins followed by forskolin addition by FLIPR assay | B | 5.09 | pEC50 | 8200 | nM | EC50 | J Med Chem (2021) 64: 7241-7260 [PMID:34028270] |
ChEMBL | Potentiation of CFTR F508del mutant activity (unknown origin) | B | 5.15 | pEC50 | 7000 | nM | EC50 | Eur J Med Chem (2020) 204: 112631-112631 [PMID:32898816] |
ChEMBL | Potentiation of CFTR F508del mutant (unknown origin) expressed in FRT cells assessed as chloride transport by measuring membrane potential in presence of forskolin | B | 5.21 | pEC50 | 6170 | nM | EC50 | J Med Chem (2021) 64: 7241-7260 [PMID:34028270] |
ChEMBL | Agonist activity at CFTR-deltaF508 mutant expressed in NIH3T3 cells assessed as increase in forskolin-stimulated current | F | 5.36 | pEC50 | 4400 | nM | EC50 | Bioorg Med Chem Lett (2008) 18: 3874-3877 [PMID:18595696] |
CFTR/Cystic fibrosis transmembrane conductance regulator in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3992] [GtoPdb: 707] [UniProtKB: P34158] | ||||||||
ChEMBL | Kd (half effective concentration) of compound against CFTR (cystic fibrosis transmembrane conductance regulator) in rat was determined | B | 4.4 | pKd | 40000 | nM | Kd | Bioorg Med Chem Lett (2003) 13: 2509-2512 [PMID:12852954] |
CYP19A1/Cytochrome P450 19A1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1978] [GtoPdb: 1362] [UniProtKB: P11511] | ||||||||
ChEMBL | Inhibition of human aromatase expressed in CHO cells | B | 4 | pKi | 100000 | nM | Ki | Bioorg Med Chem (2008) 16: 8466-8470 [PMID:18778944] |
death associated protein kinase 1/Death-associated protein kinase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2558] [GtoPdb: 2002] [UniProtKB: P53355] | ||||||||
ChEMBL | Displacement of ANS from DAPK1 catalytic domain (1 to 285) (unknown origin) after 30 mins by fluorescence assay | B | 4.01 | pIC50 | 98000 | nM | IC50 | J Med Chem (2015) 58: 7400-7408 [PMID:26322379] |
dipeptidyl peptidase 4/Dipeptidyl peptidase IV in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL284] [GtoPdb: 1612] [UniProtKB: P27487] | ||||||||
ChEMBL | Inhibition of DPP4 (unknown origin) using Gly-Pro-AMC as substrate preincubated for 4 secs followed by substrate addition and measured after 30 mins by luminescence assay | B | 6.32 | pIC50 | 480 | nM | IC50 | Eur J Med Chem (2018) 151: 145-157 [PMID:29609120] |
DNA methyltransferase 1/DNA (cytosine-5)-methyltransferase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1993] [GtoPdb: 2605] [UniProtKB: P26358] | ||||||||
ChEMBL | Inhibition of His6-tagged human recombinant DNMT1 expressed in insect Sf9 cells assessed as reduction in DNA methyltransferase activity using 5'-biotinylated 45-bp unmethylated or hemimethylated oligonucleotide substrates and [3H]-AdoMet by liquid scintillation counting method | B | 4.52 | pIC50 | 30000 | nM | IC50 | J Med Chem (2015) 58: 2569-2583 [PMID:25406944] |
DNA polymerase eta in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5542] [UniProtKB: Q9Y253] | ||||||||
ChEMBL | Inhibition of C-terminal 6xHis-tagged human DNA polymerase eta (1 to 511 residues) expressed in Escherichia coli BL21 DE3 using 5'-IRD700-GCAGGTCGACTCCAAAG-3' primer/ 5'-TCGGTACCGGGTTAGCCTTTGGAGTCGACCTGC-3' template as DNA substrate incubated for 60 mins in presence of Mg2+ by bromophenol blue staining based assay | B | 4.03 | pIC50 | 92400 | nM | IC50 | Eur J Med Chem (2023) 248: 115044-115044 [PMID:36621139] |
DNA (cytosine-5-)-methyltransferase 3α/DNMT3A2/3L complex in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL3137291] [GtoPdb: 2750] [UniProtKB: Q9UJW3, Q9Y6K1] | ||||||||
ChEMBL | Inhibition of His6-tagged human recombinant DNMT3A/DNMT3L expressed in insect Sf9 cells assessed as reduction in DNA methyltransferase activity using 5'-biotinylated 45-bp unmethylated or hemimethylated oligonucleotide substrates and [3H]-AdoMet by liquid scintillation counting method | B | 4 | pIC50 | >100000 | nM | IC50 | J Med Chem (2015) 58: 2569-2583 [PMID:25406944] |
DAT/Dopamine transporter in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL238] [GtoPdb: 927] [UniProtKB: Q01959] | ||||||||
ChEMBL | DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55) | B | 4.87 | pKi | 13442 | nM | Ki | DrugMatrix in vitro pharmacology data |
ChEMBL | DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55) | B | 4.77 | pIC50 | 16918 | nM | IC50 | DrugMatrix in vitro pharmacology data |
mitogen-activated protein kinase kinase 4/Dual specificity mitogen-activated protein kinase kinase 4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2897] [GtoPdb: 2065] [UniProtKB: P45985] | ||||||||
ChEMBL | Inhibition of recombinant human MEK4 (14 to 377 residues) after 5 mins by Western blot analysis | B | 6.4 | pIC50 | 400 | nM | IC50 | Bioorg Med Chem Lett (2020) 30: 127203-127203 [PMID:32389527] |
epidermal growth factor receptor/Epidermal growth factor receptor erbB1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL203] [GtoPdb: 1797] [UniProtKB: P00533] | ||||||||
ChEMBL | Inhibition of EGFR (unknown origin) expressed in HEK293 cells assessed as decrease in phosphorylation by chemiluminescence assay | B | 4.6 | pIC50 | 25120 | nM | IC50 | Bioorg Med Chem Lett (2014) 24: 4659-4663 [PMID:25205190] |
ChEMBL | Inhibition of wild type EGFR | B | 5.59 | pIC50 | 2600 | nM | IC50 | Proc Natl Acad Sci U S A (2007) 104: 20523-20528 [PMID:18077363] |
ChEMBL | Inhibitory activity against recombinant tyrosine kinase EGF-R (EGF-R ICD) | B | 6 | pIC50 | 1000 | nM | IC50 | J Med Chem (1994) 37: 1015-1027 [PMID:8151612] |
ChEMBL | Inhibition of Epidermal growth factor receptor | B | 6 | pIC50 | 1000 | nM | IC50 | J Med Chem (1999) 42: 1018-1026 [PMID:10090785] |
ChEMBL | In vitro inhibition of the Epidermal growth factor receptor activity in A431 membranes | B | 6 | pIC50 | 1000 | nM | IC50 | J Med Chem (1995) 38: 2441-2448 [PMID:7608909] |
ChEMBL | Inhibition of EGFR (unknown origin) | B | 6.22 | pIC50 | 600 | nM | IC50 | J Med Chem (2022) 65: 935-954 [PMID:33970631] |
Estradiol 17-beta-dehydrogenase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3181] [UniProtKB: P14061] | ||||||||
ChEMBL | Inhibition of human recombinant 17beta-HSD1 expressed in HEK293 cell lysate assessed as conversion of radiolabeled estrone to estradiol | B | 5.66 | pIC50 | 2210 | nM | IC50 | J Med Chem (2008) 51: 4188-4199 [PMID:18533708] |
hydroxysteroid 17-beta dehydrogenase 2/Estradiol 17-beta-dehydrogenase 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2789] [GtoPdb: 3094] [UniProtKB: P37059] | ||||||||
ChEMBL | Inhibition of human recombinant 17beta-HSD2 expressed in HEK293 cell lysate assessed as conversion of radiolabeled estrone to estradiol | B | 4.78 | pIC50 | 16500 | nM | IC50 | J Med Chem (2008) 51: 4188-4199 [PMID:18533708] |
ChEMBL | Inhibition of human 17beta-HSD2 expressed in HEK293 cell lysates incubated for 10 mins using [2,4,6,7-3H]-estradiol and NAD+ by scintillation counting method | B | 4.78 | pIC50 | 16500 | nM | IC50 | J Nat Prod (2017) 80: 965-974 [PMID:28319389] |
Estrogen receptor-α/Estrogen receptor alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL206] [GtoPdb: 620] [UniProtKB: P03372] | ||||||||
ChEMBL | Inhibition of binding of 17 beta-estradiol to human Estrogen receptor alpha | B | 6.43 | pKi | 370 | nM | Ki | Bioorg Med Chem Lett (2001) 11: 1839-1842 [PMID:11459643] |
ChEMBL | DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol) | B | 7.41 | pKi | 39 | nM | Ki | DrugMatrix in vitro pharmacology data |
ChEMBL | Binding affinity towards estrogen receptor alpha by [3H]17-beta-estradiol displacement. | B | 5.21 | pIC50 | 6100 | nM | IC50 | Bioorg Med Chem Lett (2004) 14: 2327-2330 [PMID:15081034] |
ChEMBL | Displacement of EL red from human full-length ER-alpha expressed in baculovirus expression system incubated for 2 hrs by fluorescence polarization assay | B | 5.32 | pIC50 | 4735 | nM | IC50 | Eur J Med Chem (2022) 241: 114658-114658 [PMID:35964426] |
ChEMBL | Binding Assay: The binding affinity and selectivity of candidate molecules yielded from database screening were determined by a fluorescent polarization competitive binding assay using purified baculovirus-expressed human ER beta or ER alpha and a fluorescent estrogen ligand EL Red (PanVera Corp.). | B | 5.33 | pIC50 | 4680 | nM | IC50 | US-8552057-B2. Phytoestrogenic formulations for alleviation or prevention of neurodegenerative diseases (2013) |
ChEMBL | Binding affinity for human Estrogen receptor Alpha | B | 5.33 | pIC50 | 4660 | nM | IC50 | J Med Chem (2005) 48: 3463-3466 [PMID:15887952] |
ChEMBL | Binding affinity for human Estrogen receptor Alpha | B | 5.33 | pIC50 | 4660 | nM | IC50 | J Med Chem (2005) 48: 3463-3466 [PMID:15887952] |
ChEMBL | Binding affinity to human ERalpha | B | 5.67 | pIC50 | 2150 | nM | IC50 | J Med Chem (2007) 50: 4471-4481 [PMID:17696335] |
ChEMBL | Displacement of [3H]estrone from ER alpha | B | 5.7 | pIC50 | 1973 | nM | IC50 | J Med Chem (2006) 49: 2440-2455 [PMID:16610787] |
ChEMBL | Inhibition of binding of 17 beta-estradiol to human Estrogen receptor alpha | B | 5.89 | pIC50 | 1300 | nM | IC50 | Bioorg Med Chem Lett (2001) 11: 1839-1842 [PMID:11459643] |
ChEMBL | Displacement of [3H]E2 from human recombinant ERalpha LBD by SPA | B | 5.94 | pIC50 | 1145 | nM | IC50 | J Med Chem (2006) 49: 7357-7365 [PMID:17149865] |
ChEMBL | Displacement of [3H]17beta-estradiol from recombinant human ERalpha | B | 6.24 | pIC50 | 580 | nM | IC50 | Bioorg Med Chem (2007) 15: 5828-5836 [PMID:17574424] |
ChEMBL | Inhibitory concentration against human ER alpha expressed in Escherichia coli was determined using [3H]17-beta-estradiol as radio ligand | B | 6.4 | pIC50 | 395 | nM | IC50 | J Med Chem (2004) 47: 5021-5040 [PMID:15456246] |
ChEMBL | Binding affinity for human Estrogen receptor alpha | B | 6.4 | pIC50 | 395 | nM | IC50 | Bioorg Med Chem Lett (2004) 14: 4925-4929 [PMID:15341953] |
ChEMBL | Inhibition of [3H]17-beta-estradiol binding to human estrogen receptor alpha expressed in Escherichia coli | B | 6.4 | pIC50 | 395 | nM | IC50 | J Med Chem (2005) 48: 3953-3979 [PMID:15943471] |
ChEMBL | Binding affinity for human Estrogen receptor alpha | B | 6.4 | pIC50 | 395 | nM | IC50 | Bioorg Med Chem Lett (2005) 15: 4520-4525 [PMID:16098741] |
ChEMBL | Inhibition of human ERalpha by radioligand binding assay | B | 6.4 | pIC50 | 395 | nM | IC50 | Bioorg Med Chem Lett (2007) 17: 902-906 [PMID:17188490] |
ChEMBL | Binding affinity towards human estrogen receptor alpha(ERalpha) | B | 6.4 | pIC50 | 395 | nM | IC50 | Bioorg Med Chem Lett (2003) 13: 2399-2403 [PMID:12824043] |
ChEMBL | Displacement of [3H]estradiol from human recombinant ERalpha | B | 6.52 | pIC50 | 300 | nM | IC50 | J Nat Prod (2002) 65: 1749-1753 [PMID:12502307] |
ChEMBL | DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol) | B | 6.87 | pIC50 | 135 | nM | IC50 | DrugMatrix in vitro pharmacology data |
ChEMBL | Binding affinity against human estrogen receptor alpha in competitive binding assay | B | 7.04 | pIC50 | 92 | nM | IC50 | Bioorg Med Chem Lett (2004) 14: 1417-1421 [PMID:15006374] |
ChEMBL | Displacement of [3H]17beta-estradiol from recombinant human ERalpha expressed in 293T cells | B | 7.53 | pIC50 | 29.4 | nM | IC50 | Bioorg Med Chem Lett (2005) 15: 5562-5566 [PMID:16219463] |
ChEMBL | Inhibition of human LBD of of ERalpha | B | 8.01 | pIC50 | 9.7 | nM | IC50 | Bioorg Med Chem Lett (2007) 17: 118-122 [PMID:17049855] |
ChEMBL | Inhibition of [3H]17-beta-estradiol binding to human recombinant Estrogen receptor alpha. | B | 5.41 | pEC50 | 3920 | nM | EC50 | J Med Chem (2002) 45: 1399-1401 [PMID:11906280] |
ChEMBL | Ability to activate estrogen receptor 1-mediated transcription. | F | 6.02 | pEC50 | 950 | nM | EC50 | Bioorg Med Chem Lett (2004) 14: 2327-2330 [PMID:15081034] |
ChEMBL | Agonist activity at human ERalpha expressed in yeast AH109 by yeast two hybrid assay | F | 6.09 | pEC50 | 810 | nM | EC50 | Bioorg Med Chem (2007) 15: 5828-5836 [PMID:17574424] |
ChEMBL | Agonist activity at human ER-alpha transfected in HEK293 cells after 48 hrs by luciferase reporter gene assay | B | 6.3 | pEC50 | 501.19 | nM | EC50 | Medchemcomm (2013) 4: 1439-1442 |
ChEMBL | Activation of estrogen response element in HeLa cells stably transfected with human Estrogen receptor alpha. | B | 7.32 | pEC50 | 48 | nM | EC50 | J Med Chem (2002) 45: 1399-1401 [PMID:11906280] |
ChEMBL | Transcriptional potency (EC50) at Human estrogen receptor alpha | B | 7.7 | pEC50 | 20 | nM | EC50 | J Med Chem (2001) 44: 4230-4251 [PMID:11708925] |
Estrogen receptor-β/Estrogen receptor beta in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL242] [GtoPdb: 621] [UniProtKB: Q92731] | ||||||||
ChEMBL | Inhibition of binding of 17 beta-estradiol to human Estrogen receptor beta | B | 7.62 | pKi | 24 | nM | Ki | Bioorg Med Chem Lett (2001) 11: 1839-1842 [PMID:11459643] |
GtoPdb | - | - | 8.2 | pKi | - | - | - | Endocrinology (1997) 138: 863-70 [PMID:9048584] |
ChEMBL | DRUGMATRIX: Estrogen ERbeta radioligand binding (ligand: [3H] Estradiol) | B | 9.23 | pKi | 0.59 | nM | Ki | DrugMatrix in vitro pharmacology data |
ChEMBL | Binding affinity to human ERbeta | B | 4.34 | pIC50 | 45900 | nM | IC50 | J Med Chem (2007) 50: 4471-4481 [PMID:17696335] |
ChEMBL | Inhibition of human LBD of ERbeta | B | 6.4 | pIC50 | 395 | nM | IC50 | Bioorg Med Chem Lett (2007) 17: 118-122 [PMID:17049855] |
ChEMBL | Binding affinity towards estrogen receptor beta by [3H]17-beta-estradiol displacement. | B | 6.41 | pIC50 | 390 | nM | IC50 | Bioorg Med Chem Lett (2004) 14: 2327-2330 [PMID:15081034] |
ChEMBL | Binding Assay: The binding affinity and selectivity of candidate molecules yielded from database screening were determined by a fluorescent polarization competitive binding assay using purified baculovirus-expressed human ER beta or ER alpha and a fluorescent estrogen ligand EL Red (PanVera Corp.). | B | 7.01 | pIC50 | 98.7 | nM | IC50 | US-8552057-B2. Phytoestrogenic formulations for alleviation or prevention of neurodegenerative diseases (2013) |
ChEMBL | Binding affinity for human Estrogen receptor beta | B | 7.01 | pIC50 | 98.7 | nM | IC50 | J Med Chem (2005) 48: 3463-3466 [PMID:15887952] |
ChEMBL | Binding affinity for human Estrogen receptor beta | B | 7.01 | pIC50 | 98.7 | nM | IC50 | J Med Chem (2005) 48: 3463-3466 [PMID:15887952] |
ChEMBL | Inhibition of binding of 17 beta-estradiol to human Estrogen receptor beta | B | 7.08 | pIC50 | 83 | nM | IC50 | Bioorg Med Chem Lett (2001) 11: 1839-1842 [PMID:11459643] |
ChEMBL | Displacement of EL red from human full-length ER-beta expressed in baculovirus expression system incubated for 2 hrs by fluorescence polarization assay | B | 7.11 | pIC50 | 78 | nM | IC50 | Eur J Med Chem (2022) 241: 114658-114658 [PMID:35964426] |
ChEMBL | Displacement of [3H]estrone from ER beta | B | 7.21 | pIC50 | 61 | nM | IC50 | J Med Chem (2006) 49: 2440-2455 [PMID:16610787] |
ChEMBL | Displacement of [3H]E2 from human recombinant ERbeta LBD by SPA | B | 7.6 | pIC50 | 25 | nM | IC50 | J Med Chem (2006) 49: 7357-7365 [PMID:17149865] |
ChEMBL | Displacement of [3H]estradiol from human recombinant ERbeta | B | 7.74 | pIC50 | 18 | nM | IC50 | J Nat Prod (2002) 65: 1749-1753 [PMID:12502307] |
ChEMBL | Binding affinity for human Estrogen receptor beta | B | 8 | pIC50 | 10 | nM | IC50 | Bioorg Med Chem Lett (2004) 14: 4925-4929 [PMID:15341953] |
ChEMBL | Binding affinity towards human estrogen receptor beta (ERbeta) | B | 8 | pIC50 | 10 | nM | IC50 | Bioorg Med Chem Lett (2003) 13: 2399-2403 [PMID:12824043] |
ChEMBL | Binding affinity for human Estrogen receptor beta | B | 8 | pIC50 | 10 | nM | IC50 | Bioorg Med Chem Lett (2005) 15: 4520-4525 [PMID:16098741] |
ChEMBL | Inhibitory concentration against human ER beta expressed in Escherichia coli was determined using [3H]17-beta-estradiol as radio ligand | B | 8 | pIC50 | 10 | nM | IC50 | J Med Chem (2004) 47: 5021-5040 [PMID:15456246] |
ChEMBL | Inhibition of human ERbeta by radioligand binding assay | B | 8.01 | pIC50 | 9.7 | nM | IC50 | Bioorg Med Chem Lett (2007) 17: 902-906 [PMID:17188490] |
ChEMBL | Inhibition of [3H]17-beta-estradiol binding to human estrogen receptor beta expressed in Escherichia coli | B | 8.01 | pIC50 | 9.7 | nM | IC50 | J Med Chem (2005) 48: 3953-3979 [PMID:15943471] |
ChEMBL | Displacement of [3H]17beta-estradiol from recombinant human ERbeta | B | 8.17 | pIC50 | 6.8 | nM | IC50 | Bioorg Med Chem (2007) 15: 5828-5836 [PMID:17574424] |
ChEMBL | Binding affinity against human estrogen receptor beta (ER beta) in competitive binding assay | B | 8.4 | pIC50 | 4 | nM | IC50 | Bioorg Med Chem Lett (2004) 14: 1417-1421 [PMID:15006374] |
ChEMBL | DRUGMATRIX: Estrogen ERbeta radioligand binding (ligand: [3H] Estradiol) | B | 8.54 | pIC50 | 2.88 | nM | IC50 | DrugMatrix in vitro pharmacology data |
ChEMBL | Displacement of [3H]17beta-estradiol from recombinant human ERbeta expressed in 293T cells | B | 8.89 | pIC50 | 1.3 | nM | IC50 | Bioorg Med Chem Lett (2005) 15: 5562-5566 [PMID:16219463] |
ChEMBL | Inhibition of ER beta-mediated transactivation of ERE in HeLa cell luciferase assay at 10 uM | F | 6.02 | pEC50 | 956 | nM | EC50 | J Med Chem (2006) 49: 2440-2455 [PMID:16610787] |
ChEMBL | Ability to activate estrogen receptor 2-mediated transcription. | F | 6.7 | pEC50 | 200 | nM | EC50 | Bioorg Med Chem Lett (2004) 14: 2327-2330 [PMID:15081034] |
ChEMBL | Inhibition of [3H]17-beta-estradiol binding to human recombinant Estrogen receptor beta. | B | 6.7 | pEC50 | 200 | nM | EC50 | J Med Chem (2002) 45: 1399-1401 [PMID:11906280] |
ChEMBL | Inhibition of ER beta-mediated transactivation of ERE in HeLa cell luciferase assay | F | 7.14 | pEC50 | 73 | nM | EC50 | J Med Chem (2006) 49: 2440-2455 [PMID:16610787] |
ChEMBL | Agonist activity at human ERbeta expressed in yeast AH109 by yeast two hybrid assay | F | 7.55 | pEC50 | 28 | nM | EC50 | Bioorg Med Chem (2007) 15: 5828-5836 [PMID:17574424] |
ChEMBL | Agonist activity at human ER-beta transfected in HEK293 cells after 48 hrs by luciferase reporter gene assay | B | 7.7 | pEC50 | 19.95 | nM | EC50 | Medchemcomm (2013) 4: 1439-1442 |
ChEMBL | Transcriptional potency (EC50) at Human estrogen receptor Beta | B | 8.22 | pEC50 | 6 | nM | EC50 | J Med Chem (2001) 44: 4230-4251 [PMID:11708925] |
ChEMBL | Activation of estrogen response element in HeLa cells stably transfected with human Estrogen receptor beta. | B | 8.39 | pEC50 | 4.1 | nM | EC50 | J Med Chem (2002) 45: 1399-1401 [PMID:11906280] |
ChEMBL | Estrogenic activity at ERbeta (unknown origin) expressed in human MDA-MB-231/beta41 cells after 18 hrs by renilla luciferase reporter gene assay | B | 8.62 | pEC50 | 2.4 | nM | EC50 | J Nat Prod (2018) 81: 966-975 [PMID:29641206] |
ChEMBL | Agonist activity in transcriptional activation assay in SH-SY5Y neuroblastoma cells expressing Estrogen receptor beta | F | 8.77 | pEC50 | 1.7 | nM | EC50 | J Med Chem (2002) 45: 1399-1401 [PMID:11906280] |
Estrogen-related receptor-α/Estrogen-related receptor alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3429] [GtoPdb: 622] [UniProtKB: P11474] | ||||||||
ChEMBL | Inhibition of human ERalpha | B | 8 | pIC50 | 10 | nM | IC50 | Bioorg Med Chem Lett (2007) 17: 4053-4056 [PMID:17482813] |
Estrogen-related receptor-β/Estrogen-related receptor beta in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3751] [GtoPdb: 623] [UniProtKB: O95718] | ||||||||
ChEMBL | Inhibition of human ERbeta | B | 6.4 | pIC50 | 395 | nM | IC50 | Bioorg Med Chem Lett (2007) 17: 4053-4056 [PMID:17482813] |
Fatty acid synthase in Plasmodium falciparum (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4512] [UniProtKB: Q965D7] | ||||||||
ChEMBL | Inhibition of FabZ | B | 5.15 | pIC50 | 7000 | nM | IC50 | J Med Chem (2006) 49: 3345-3353 [PMID:16722653] |
Glucose transporter 1/Glucose transporter in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2535] [GtoPdb: 875] [UniProtKB: P11166] | ||||||||
ChEMBL | Competitive inhibition of glucose displaceable binding of [4-3H]cytochalasin B to GLUT1 in human erythrocyte membranes after 10 mins by double reciprocal plot analysis | B | 5.15 | pKi | 7000 | nM | Ki | Medchemcomm (2016) 7: 1716-1729 [PMID:28042452] |
ChEMBL | Competitive inhibition of GLUT1 (unknown origin) expressed in CHO cells assessed as reduction in 2-[1,2-3H]deoxy-D-glucose uptake measured for 30 secs by double reciprocal plot analysis | B | 5.15 | pKi | 7000 | nM | Ki | Medchemcomm (2016) 7: 1716-1729 [PMID:28042452] |
ChEMBL | Competitive inhibition of GLUT1 in human HL60 cells assessed as reduction in 2-[1,2-3H]deoxy-D-glucose uptake measured for 30 secs by double reciprocal plot analysis | B | 5.15 | pKi | 7000 | nM | Ki | Medchemcomm (2016) 7: 1716-1729 [PMID:28042452] |
histone deacetylase 6/Histone deacetylase 6 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1865] [GtoPdb: 2618] [UniProtKB: Q9UBN7] | ||||||||
ChEMBL | Determination of IC50 values for inhibition of enzymatic assay of human HDAC6 with custom peptide substrate | B | 5.72 | pIC50 | 1885 | nM | IC50 | HDAC6 screening dataset using tau-based substrate in an enzymatic assay yields selective inhibitors and activators |
Human immunodeficiency virus type 1 integrase in Human immunodeficiency virus 1 (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3471] [UniProtKB: Q7ZJM1] | ||||||||
ChEMBL | Inhibition of recombinant HIV-1 integrase 3'-processing activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis | B | 4.7 | pIC50 | >20000 | nM | IC50 | Bioorg Med Chem (2014) 22: 3146-3158 [PMID:24794743] |
ChEMBL | Inhibition of recombinant HIV-1 integrase strand transfer activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis | B | 4.7 | pIC50 | >20000 | nM | IC50 | Bioorg Med Chem (2014) 22: 3146-3158 [PMID:24794743] |
ChEMBL | Inhibition of His6-tagged HIV-1 integrase assessed as decrease in integrase-Flag-LEDGF/p75 interaction preincubated with enzyme for 30 mins followed by addition of Flag-LEDGF/p75 for 1 hr by AlphaScreen assay | B | 5.96 | pIC50 | 1100 | nM | IC50 | Bioorg Med Chem (2014) 22: 3146-3158 [PMID:24794743] |
Liver X receptor-α/LXR-alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2808] [GtoPdb: 602] [UniProtKB: Q13133] | ||||||||
ChEMBL | Antagonist activity at human recombinant LXRalpha expressed in HEK293 cells by luciferase reporter gene assay | F | 4.51 | pIC50 | 31000 | nM | IC50 | Bioorg Med Chem (2008) 16: 4272-4285 [PMID:18343126] |
Liver X receptor-β/LXR-beta in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4093] [GtoPdb: 601] [UniProtKB: P55055] | ||||||||
ChEMBL | Antagonist activity at human recombinant LXRbeta expressed in HEK293 cells by luciferase reporter gene assay | F | 4.66 | pIC50 | 22000 | nM | IC50 | Bioorg Med Chem (2008) 16: 4272-4285 [PMID:18343126] |
maltase-glucoamylase/Maltase-glucoamylase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2074] [GtoPdb: 2627] [UniProtKB: O43451] | ||||||||
ChEMBL | Inhibition kinetics of yeast alpha-glucosidase by genistein at a concentration of 10.2 uM | B | 4.98 | pKi | 10400 | nM | Ki | Bioorg Med Chem Lett (2004) 14: 2947-2950 [PMID:15125965] |
ChEMBL | Inhibition of yeast alpha-glucosidase by genistein | B | 4.98 | pIC50 | 10400 | nM | IC50 | Bioorg Med Chem Lett (2004) 14: 2947-2950 [PMID:15125965] |
ChEMBL | Inhibition of yeast alpha-glucosidase after addition of D-glucose | B | 5.58 | pIC50 | 2610 | nM | IC50 | Bioorg Med Chem Lett (2004) 14: 2947-2950 [PMID:15125965] |
Monoamine oxidase A in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1951] [GtoPdb: 2489] [UniProtKB: P21397] | ||||||||
ChEMBL | Inhibition of recombinant human MAO-A expressed in baculovirus infected BTI insect cells assessed as decrease in arbitrary light units preincubated for 40 mins followed by addition of luciferin derivative substrate measured after 2 hrs by MAO-Glow assay | B | 5.01 | pIC50 | 9700 | nM | IC50 | Bioorg Med Chem Lett (2016) 26: 4714-4719 [PMID:27575476] |
ChEMBL | Inhibition of human recombinant MAOA using kynuramine as substrate preincubated for 30 mins followed by substrate addition | B | 5.41 | pIC50 | 3900 | nM | IC50 | Bioorg Med Chem Lett (2018) 28: 584-588 [PMID:29395970] |
ChEMBL | Inhibition of recombinant human MAO-A expressed in baculovirus infected BTI insect cells preincubated for 10 mins followed by addition of kynuramine as substrate | B | 5.41 | pIC50 | 3900 | nM | IC50 | Bioorg Med Chem Lett (2016) 26: 4714-4719 [PMID:27575476] |
ChEMBL | DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine) | B | 5.6 | pIC50 | 2520 | nM | IC50 | DrugMatrix in vitro pharmacology data |
Monoamine oxidase A in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3358] [UniProtKB: P21396] | ||||||||
ChEMBL | Inhibition of rat brain mitochondrial MAO-A preincubated for 15 mins followed by addition of serotonin as substrate measured after 90 mins | B | 4.4 | pIC50 | 40000 | nM | IC50 | Bioorg Med Chem Lett (2016) 26: 4714-4719 [PMID:27575476] |
Monoamine oxidase B in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2039] [GtoPdb: 2490] [UniProtKB: P27338] | ||||||||
ChEMBL | Inhibition of human MAO-B | B | 5.17 | pIC50 | 6810 | nM | IC50 | Eur J Med Chem (2018) 152: 570-589 [PMID:29763806] |
ChEMBL | Inhibition of recombinant human MAO-B expressed in baculovirus infected BTI insect cells assessed as decrease in arbitrary light units preincubated for 40 mins followed by addition of luciferin derivative substrate measured after 2 hrs by MAO-Glow assay | B | 5.17 | pIC50 | 6800 | nM | IC50 | Bioorg Med Chem Lett (2016) 26: 4714-4719 [PMID:27575476] |
ChEMBL | Inhibition of recombinant human MAO-B expressed in baculovirus infected BTI insect cells preincubated for 10 mins followed by addition of benzylamine as substrate | B | 5.39 | pIC50 | 4100 | nM | IC50 | Bioorg Med Chem Lett (2016) 26: 4714-4719 [PMID:27575476] |
ChEMBL | Inhibition of recombinant human MAO-B using kynuramine as substrate preincubated for 10 mins followed by substrate addition and measured after 20 mins by fluorometric assay | B | 6.19 | pIC50 | 650 | nM | IC50 | Eur J Med Chem (2020) 206: 112787-112787 [PMID:32942081] |
Neuraminidase in Influenza A virus (A/Puerto Rico/8/1934(H1N1)) (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2051] [UniProtKB: P03468] | ||||||||
ChEMBL | Inhibition of Influenza A PR/8/34 H1N1 virus neuraminidase activity by MUN-ANA substrate based fluorimetric assay | B | 1.32 | pIC50 | 1.32 | - | logIC50 | Eur J Med Chem (2010) 45: 1724-1730 [PMID:20116898] |
Neuraminidase in Influenza A virus (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL6135] [UniProtKB: B4URF0] | ||||||||
ChEMBL | Inhibition of Influenza A Jiangsu/10/2003 virus neuraminidase activity by MUN-ANA substrate based fluorimetric assay | B | 4.08 | pIC50 | 83300 | nM | IC50 | Bioorg Med Chem (2008) 16: 7141-7147 [PMID:18640042] |
ChEMBL | Inhibition of Influenza A PR/8/34 H1N1 virus neuraminidase activity by MUN-ANA substrate based fluorimetric assay | B | 4.11 | pIC50 | 77100 | nM | IC50 | Bioorg Med Chem (2008) 16: 7141-7147 [PMID:18640042] |
Ornithine decarboxylase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1869] [GtoPdb: 1276] [UniProtKB: P11926] | ||||||||
ChEMBL | Inhibition of phorbol ester-induced ornithine decarboxylase in human MCF7 cells after 6 hrs | B | 4.59 | pIC50 | 26000 | nM | IC50 | J Nat Prod (1999) 62: 205-210 [PMID:10075742] |
Pancreatic triacylglycerol lipase in Pig (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1687677] [UniProtKB: P00591] | ||||||||
ChEMBL | Inhibition of porcine pancreatic lipase pre-incubated for 15 mins before p-nitrophenylbutyrate substrate addition by microplate reader based method | B | 4 | pIC50 | >100000 | nM | IC50 | Bioorg Med Chem Lett (2015) 25: 3455-3457 [PMID:26227773] |
ABCB1/P-glycoprotein 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4302] [GtoPdb: 768] [UniProtKB: P08183] | ||||||||
ChEMBL | Binding affinity to ABCB1 nucleotide binding domain 2 | B | 4.58 | pKd | 26302.68 | nM | Kd | Eur J Med Chem (2011) 46: 4078-4088 [PMID:21723648] |
Plasmodium berghei (target type: ORGANISM) [ChEMBL: CHEMBL612653] | ||||||||
ChEMBL | Antimalarial activity against liver stages of Plasmodium berghei | F | 4.7 | pIC50 | 20000 | nM | IC50 | J Med Chem (2012) 55: 995-1012 [PMID:22122518] |
ChEMBL | Antiplasmodial activity against liver sporozoite stage of Plasmodium berghei ANKA expressing GFP infected in human HuH7 cells assessed as inhibition of parasite development after 24 hrs by qRT-PCR analysis | F | 4.7 | pIC50 | 20000 | nM | IC50 | Eur J Med Chem (2013) 69: 872-880 [PMID:24125849] |
Plasmodium falciparum (target type: ORGANISM) [ChEMBL: CHEMBL364] | ||||||||
ChEMBL | Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum NF54 | F | 4.42 | pIC50 | 38200 | nM | IC50 | J Med Chem (2006) 49: 3345-3353 [PMID:16722653] |
proteasome 20S subunit beta 5/Proteasome Macropain subunit MB1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4662] [GtoPdb: 2406] [UniProtKB: P28074] | ||||||||
ChEMBL | Inhibition of chymotrypsin-like activity of human 26S proteasome extracted from human LNCap cells assessed as decrease in AMC hydrolysis using Suc-Leu-Leu-Val-Tyr-AMC as substrate incubated for 60 mins by fluorescence based method | B | 4.19 | pIC50 | 65000 | nM | IC50 | Eur J Med Chem (2019) 167: 291-311 [PMID:30776692] |
ChEMBL | Inhibition of chymotrypsin-like activity of purified human erythrocyte 20S proteasome assessed as decrease in AMC hydrolysis using Suc-LLVY-AMC as substrate preincubated for 10 mins and measured by fluorescence based method | B | 5.03 | pIC50 | 9260 | nM | IC50 | Eur J Med Chem (2019) 167: 291-311 [PMID:30776692] |
protein kinase C alpha/Protein kinase C alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL299] [GtoPdb: 1482] [UniProtKB: P17252] | ||||||||
ChEMBL | Inhibition of Protein kinase C alpha | B | 4 | pIC50 | >100000 | nM | IC50 | J Med Chem (1999) 42: 1018-1026 [PMID:10090785] |
Protein kinase Pfmrk in Plasmodium falciparum (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4090] [UniProtKB: P90584] | ||||||||
ChEMBL | Inhibition of Plasmodium falciparum cyclin-dependent kinase | B | 4.03 | pIC50 | 93000 | nM | IC50 | J Med Chem (2004) 47: 5418-5426 [PMID:15481979] |
AKT serine/threonine kinase 1/Serine/threonine-protein kinase AKT in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4282] [GtoPdb: 1479] [UniProtKB: P31749] | ||||||||
ChEMBL | Inhibition of Akt by fluorescence polarization assay | B | 4.15 | pIC50 | >70000 | nM | IC50 | J Med Chem (2006) 49: 3800-3808 [PMID:16789737] |
5-HT2A receptor/Serotonin 2a (5-HT2a) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL224] [GtoPdb: 6] [UniProtKB: P28223] | ||||||||
ChEMBL | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) | B | 5.52 | pKi | 2991 | nM | Ki | DrugMatrix in vitro pharmacology data |
ChEMBL | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) | B | 4.98 | pIC50 | 10469 | nM | IC50 | DrugMatrix in vitro pharmacology data |
5-HT2C receptor/Serotonin 2c (5-HT2c) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL225] [GtoPdb: 8] [UniProtKB: P28335] | ||||||||
ChEMBL | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) | B | 5.11 | pKi | 7806 | nM | Ki | DrugMatrix in vitro pharmacology data |
ChEMBL | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) | B | 4.83 | pIC50 | 14910 | nM | IC50 | DrugMatrix in vitro pharmacology data |
Sialidase in Clostridium perfringens (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5189] [UniProtKB: P10481] | ||||||||
ChEMBL | Inhibition of Clostridium perfringens neuraminidase using 4-methylumbelliferyl-alpha-D-N-acetylneuraminic acid sodium salt hydrate as substrate by fluorimetry | B | 4.92 | pIC50 | 12050 | nM | IC50 | Bioorg Med Chem (2013) 21: 6398-6404 [PMID:24054487] |
signal transducer and activator of transcription 3/Signal transducer and activator of transcription 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4026] [GtoPdb: 2994] [UniProtKB: P40763] | ||||||||
ChEMBL | Inhibition of IL-6-Induced STAT3 activation (unknown origin) expressed in human HepG2 cells expressing pSTAT3-luciferase pre-incubated for 1 hr before IL-6 stimulation for 6 hrs by luciferase reporter gene assay | B | 4.61 | pIC50 | 24800 | nM | IC50 | J Nat Prod (2017) 80: 3103-3111 [PMID:29140705] |
Glucose transporter 4/Solute carrier family 2, facilitated glucose transporter member 4 in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1250410] [GtoPdb: 878] [UniProtKB: P14142] | ||||||||
ChEMBL | Inhibition of GLUT4 in mouse 3T3L1 cells assessed as reduction in insulin-stimulated 2-deoxy-D-[14C]glucose uptake | B | 4.7 | pIC50 | 20000 | nM | IC50 | Medchemcomm (2016) 7: 1716-1729 [PMID:28042452] |
OATP2B1/Solute carrier organic anion transporter family member 2B1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1743124] [GtoPdb: 1224] [UniProtKB: O94956] | ||||||||
ChEMBL | Inhibition of human OATP2B1 expressed in Flp-In-CHO cells assessed as inhibition of OATP2B1 mediated DBF uptake using DBF as fluorescent substrate incubated for 2 mins by BCA assay | B | 5.28 | pIC50 | 5300 | nM | IC50 | RSC Med Chem (2023) 14: 890-898 [PMID:37252098] |
ChEMBL | Inhibition of human OATP2B1 expressed in Flp-In-CHO cells assessed as inhibition of OATP2B1 mediated DBF uptake using DBF as fluorescent substrate incubated for 2 mins by BCA assay | B | 5.28 | pIC50 | 5248.07 | nM | IC50 | RSC Med Chem (2023) 14: 890-898 [PMID:37252098] |
Testis-specific androgen-binding protein in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3305] [UniProtKB: P04278] | ||||||||
ChEMBL | Displacement of [3H]5alpha dihydrotestosterone from human sex hormone binding globulin | B | 4.4 | pKd | 39810.72 | nM | Kd | J Med Chem (2008) 51: 2047-2056 [PMID:18330978] |
CYP5A1/Thromboxane-A synthase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1835] [GtoPdb: 1353] [UniProtKB: P24557] | ||||||||
ChEMBL | DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2) | B | 5.11 | pIC50 | 7720 | nM | IC50 | DrugMatrix in vitro pharmacology data |
transthyretin/Transthyretin in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3194] [GtoPdb: 2851] [UniProtKB: P02766] | ||||||||
ChEMBL | Inhibition of transthyretin V30M mutant (unknown origin) expressed in Escherichia coli assessed as inhibition of sodium acetate-mediated aggregation preincubated for 30 mins followed by sodium acetate addition measured after 96 hrs by thioflavin T assay | B | 5.11 | pIC50 | 7800 | nM | IC50 | J Med Chem (2014) 57: 1090-1096 [PMID:24422526] |
ABL proto-oncogene 1, non-receptor tyrosine kinase/Tyrosine-protein kinase ABL in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1862] [GtoPdb: 1923] [UniProtKB: P00519] | ||||||||
ChEMBL | In vitro inhibition of the v-abl tyrosine kinase activity in A431 membranes using angiotensin II as phosphate acceptor as substrate | B | 5 | pIC50 | 10000 | nM | IC50 | J Med Chem (1995) 38: 2441-2448 [PMID:7608909] |
BMX non-receptor tyrosine kinase/Tyrosine-protein kinase BMX in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3834] [GtoPdb: 1942] [UniProtKB: P51813] | ||||||||
ChEMBL | Inhibition of Bmx (unknown origin) expressed in HEK293 cells assessed as decrease in phosphorylation by chemiluminescence assay | B | 4.17 | pIC50 | 67990 | nM | IC50 | Bioorg Med Chem Lett (2014) 24: 4659-4663 [PMID:25205190] |
FYN proto-oncogene, Src family tyrosine kinase/Tyrosine-protein kinase FYN in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1841] [GtoPdb: 2026] [UniProtKB: P06241] | ||||||||
ChEMBL | Inhibition of Fyn (unknown origin) expressed in HEK293 cells assessed as decrease in phosphorylation by chemiluminescence assay | B | 4.24 | pIC50 | 58180 | nM | IC50 | Bioorg Med Chem Lett (2014) 24: 4659-4663 [PMID:25205190] |
SRC proto-oncogene, non-receptor tyrosine kinase/Tyrosine-protein kinase SRC in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL267] [GtoPdb: 2206] [UniProtKB: P12931] | ||||||||
ChEMBL | Inhibition of Src (unknown origin) expressed in HEK293 cells assessed as decrease in phosphorylation by chemiluminescence assay | B | 4 | pIC50 | >100000 | nM | IC50 | Bioorg Med Chem Lett (2014) 24: 4659-4663 [PMID:25205190] |
ChEMBL | In vitro inhibition of the c-src tyrosine kinase activity in A431 membranes using angiotensin II as phosphate acceptor as substrate | B | 4.12 | pIC50 | 75000 | nM | IC50 | J Med Chem (1995) 38: 2441-2448 [PMID:7608909] |
ChEMBL | Inhibition of p60 c-Src tyrosine kinase | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (1999) 42: 1018-1026 [PMID:10090785] |
spleen associated tyrosine kinase/Tyrosine-protein kinase SYK in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2599] [GtoPdb: 2230] [UniProtKB: P43405] | ||||||||
ChEMBL | Inhibition of recombinant Syk | B | 4.41 | pIC50 | 39000 | nM | IC50 | Bioorg Med Chem Lett (2009) 19: 1944-1949 [PMID:19254842] |
Voltage-dependent L-type calcium channel subunit alpha-1C in Guinea pig (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2366456] [UniProtKB: O35505] | ||||||||
ChEMBL | Inhibition of L-type calcium channel measured using whole-cell patch clamp in guinea pig ventricular myocytes | F | 4.7 | pIC50 | 20000 | nM | IC50 | J Appl Toxicol (2012) 32: 858-866 [PMID:22761000] |
Cav1.2/Voltage-gated L-type calcium channel alpha-1C subunit in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3762] [GtoPdb: 529] [UniProtKB: P22002] | ||||||||
ChEMBL | Inhibition of Cav1.2 calcium current measured using whole cell patch clamp in rat Artery myocytes | F | 4.24 | pIC50 | 57500 | nM | IC50 | IC50 data for the L-type calcium channel extracted from a set of literature articles |
ChEMBL | Inhibition of L-type calcium channel measured using whole-cell patch clamp in rat ventricular myocytes | F | 4.96 | pIC50 | 11000 | nM | IC50 | J Appl Toxicol (2012) 32: 858-866 [PMID:22761000] |
ChEMBL | Inhibition of Cav1.2 calcium current measured using whole cell patch clamp in rat ventricular myocytes | F | 4.96 | pIC50 | 11000 | nM | IC50 | IC50 data for the L-type calcium channel extracted from a set of literature articles |
xanthine dehydrogenase/Xanthine dehydrogenase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1929] [GtoPdb: 2646] [UniProtKB: P47989] | ||||||||
ChEMBL | Inhibition of XO (unknown origin) | B | 5.45 | pIC50 | 3530 | nM | IC50 | J Med Chem (2023) 66: 14474-14493 [PMID:37908076] |
Xanthine dehydrogenase in Bovine (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3649] [UniProtKB: P80457] | ||||||||
ChEMBL | Inhibition of bovine milk xanthine oxidase assessed as reduction in uric acid formation using xanthine as substrate preincubated for 3 hrs followed by substrate addition measured after 1 min by UV spectrophotometric assay | B | 5.76 | pIC50 | 1730 | nM | IC50 | Eur J Med Chem (2017) 135: 491-516 [PMID:28478180] |
TAS2R14 in Human [GtoPdb: 668] [UniProtKB: Q9NYV8] | ||||||||
GtoPdb | - | - | 4.19 | pEC50 | 63900 | nM | EC50 | Biochim Biophys Acta Gen Subj (2018) 1862: 2162-2173 [PMID:30009876] |
TAS2R39 in Human [GtoPdb: 675] [UniProtKB: P59534] | ||||||||
GtoPdb | - | - | 4.31 | pEC50 | 49400 | nM | EC50 | J Agric Food Chem (2011) 59: 11764-71 [PMID:21942422] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]